JNJ-61610588
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JNJ-61610588, covering 2018-03-27 to 2018-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Safety, Pharmacokinetics, Pharmacodynamics of JNJ-61610588 in Participants With Advanced Cancer [Phase 1]